M7824: A promising new strategy to combat cancer immune evasion
Oncoscience
.
2018 Aug 22;5(11-12):269-270.
doi: 10.18632/oncoscience.451.
eCollection 2018 Nov.
Authors
Margaret E Gatti-Mays
1
,
James L Gulley
1
Affiliation
1
Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
PMID:
30652109
PMCID:
PMC6326736
DOI:
10.18632/oncoscience.451
No abstract available
Keywords:
M7824; PD-L1; transforming growth factor-beta.